Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
11.10
-0.04 (-0.36%)
At close: Mar 28, 2025, 4:00 PM
11.14
+0.04 (0.34%)
After-hours: Mar 28, 2025, 8:00 PM EDT

Company Description

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.

Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Enfusion, Inc.
Enfusion logo
Country United States
Founded 1998
IPO Date Oct 21, 2021
Industry Software - Application
Sector Technology
Employees 1,143
CEO Oleg Movchan

Contact Details

Address:
125 South Clark Street, Suite 750
Chicago, Illinois 60603
United States
Phone 312 253 9800
Website enfusion.com

Stock Details

Ticker Symbol ENFN
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001868912
CUSIP Number 292812104
ISIN Number US2928121043
SIC Code 7372

Key Executives

Name Position
Oleg Movchan Chief Executive Officer and Director
Bradley Herring Chief Financial Officer
Neal Pawar Chief Operating Officer
Stephen Malherbe Managing Partner
Valeria Gutowski Chief Accounting Officer
Daniel Groman Chief Technology Officer
Matthew R. Campobasso General Counsel and Corporate Secretary
Bronwen Bastone Chief People Officer
Joseph Defeo Global Head of Managed Services Production
Jeff Young Head of Implementation

Latest SEC Filings

Date Type Title
Mar 20, 2025 DEFM14A Filing
Mar 6, 2025 144 Filing
Mar 5, 2025 144 Filing
Mar 5, 2025 144 Filing
Mar 5, 2025 144 Filing
Mar 5, 2025 144 Filing
Mar 3, 2025 10-K Annual Report
Mar 3, 2025 144 Filing
Mar 3, 2025 8-K Current Report
Mar 3, 2025 144 Filing